Phase I/II study of TROP2 CAR engineered IL15-transduced cord blood-derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric-like adenocarcinoma, and pancreatic cancer.

Anne Knisely, Amir A. Jazaeri, Shannon N. Westin et al.|Journal of Clinical Oncology|2024

Cited by 9